| Style | Citing Format |
|---|---|
| MLA | Hassani D, et al.. "A Novel Tumor Inhibitory Hybridoma Monoclonal Antibody With Dual Specificity for Her3 and Her2." Current Research in Translational Medicine, vol. 69, no. 2, 2021, pp. -. |
| APA | Hassani D, Amiri MM, Mohammadi M, Yousefi P, Judaki MA, Mobini M, Golsazshirazi F, Jedditehrani M, Shokri F (2021). A Novel Tumor Inhibitory Hybridoma Monoclonal Antibody With Dual Specificity for Her3 and Her2. Current Research in Translational Medicine, 69(2), -. |
| Chicago | Hassani D, Amiri MM, Mohammadi M, Yousefi P, Judaki MA, Mobini M, Golsazshirazi F, Jedditehrani M, Shokri F. "A Novel Tumor Inhibitory Hybridoma Monoclonal Antibody With Dual Specificity for Her3 and Her2." Current Research in Translational Medicine 69, no. 2 (2021): -. |
| Harvard | Hassani D et al. (2021) 'A Novel Tumor Inhibitory Hybridoma Monoclonal Antibody With Dual Specificity for Her3 and Her2', Current Research in Translational Medicine, 69(2), pp. -. |
| Vancouver | Hassani D, Amiri MM, Mohammadi M, Yousefi P, Judaki MA, Mobini M, et al.. A Novel Tumor Inhibitory Hybridoma Monoclonal Antibody With Dual Specificity for Her3 and Her2. Current Research in Translational Medicine. 2021;69(2):-. |
| BibTex | @article{ author = {Hassani D and Amiri MM and Mohammadi M and Yousefi P and Judaki MA and Mobini M and Golsazshirazi F and Jedditehrani M and Shokri F}, title = {A Novel Tumor Inhibitory Hybridoma Monoclonal Antibody With Dual Specificity for Her3 and Her2}, journal = {Current Research in Translational Medicine}, volume = {69}, number = {2}, pages = {-}, year = {2021} } |
| RIS | TY - JOUR AU - Hassani D AU - Amiri MM AU - Mohammadi M AU - Yousefi P AU - Judaki MA AU - Mobini M AU - Golsazshirazi F AU - Jedditehrani M AU - Shokri F TI - A Novel Tumor Inhibitory Hybridoma Monoclonal Antibody With Dual Specificity for Her3 and Her2 JO - Current Research in Translational Medicine VL - 69 IS - 2 SP - EP - PY - 2021 ER - |